+627.2%
ABBV vs EMR
+270.1%
+357.0%
-45.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | EMR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.6% | -0.9% | +0.3% | -0.3% |
| 7D | -0.4% | -4.7% | +4.3% | +0.8% |
| 30D | +2.6% | -1.1% | +3.7% | +2.8% |
| 3M | +17.7% | -1.4% | +19.1% | +17.8% |
| 6M | +41.0% | +20.5% | +20.6% | +33.3% |
| YTD | +32.0% | +21.7% | +10.3% | +22.9% |
| 1Y | +28.9% | +27.3% | +1.6% | +18.4% |
| 3Y | +133.9% | +87.5% | +46.4% | +85.8% |
| 5Y | +198.0% | +86.0% | +112.0% | +132.6% |
| All | +627.2% | +270.1% | +357.0% | +382.3% |
Cumulative growth
Daily Returns
Daily percentage return beside EMR.
Daily Out/Under-Performance
Portfolio return minus EMR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EMR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded EMR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling